| 000 | 01504 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517214920.0 | ||
| 264 | 0 | _c20181009 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1752-8984 | ||
| 024 | 7 |
_a10.1177/1479164118774313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Gang | |
| 245 | 0 | 0 |
_aAltered sarco(endo)plasmic reticulum calcium adenosine triphosphatase 2a content: Targets for heart failure therapy. _h[electronic resource] |
| 260 |
_bDiabetes & vascular disease research _c07 2018 |
||
| 300 |
_a322-335 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aHeart Failure _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsoenzymes |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aSarcoplasmic Reticulum Calcium-Transporting ATPases _xantagonists & inhibitors |
| 700 | 1 | _aLi, Si Qi | |
| 700 | 1 | _aHu, Ping Ping | |
| 700 | 1 | _aTong, Xiao Yong | |
| 773 | 0 |
_tDiabetes & vascular disease research _gvol. 15 _gno. 4 _gp. 322-335 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1479164118774313 _zAvailable from publisher's website |
| 999 |
_c28392139 _d28392139 |
||